New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.
It might mean the eyes could still see when transplanted into the recipient, say the scientists behind the work.
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Andy Smith is a Certified Financial Planner ...
Strong leaders put business transformation in the hands of all employees. by H. James Wilson and Paul R. Daugherty In the late 1940s an engineer named Taiichi Ohno began developing the Toyota ...
The RIKEN Center for Computational Science (R-CCS) operates the world-class supercomputer "Fugaku," providing computational resources to a wide range of users across academia, research institutions, ...
Point-of-care ultrasound (POCUS) has moved decisively beyond its early role as a rapid diagnostic adjunct. In many acute and critical care environments, it ...
As global climate policies tighten and net zero targets draw closer, technologies such as Carbon Capture and Storage as well ...
Sheher Mohsin explains how CCS measurements add a physical confirmation layer beyond mass and retention time in PFAS analysis. Why are ion mobility and CCS measurements becoming increasingly important ...